کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
5120823 1486258 2017 8 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Are dispensaries indispensable? Patient experiences of access to cannabis from medical cannabis dispensaries in Canada
ترجمه فارسی عنوان
آیا اختلالات ضروری است؟ تجربیات بیمار از دسترسی به کانابیس از داروخانه های کانابیس پزشکی در کانادا
کلمات کلیدی
کانابیس، ماری جوانا پزشکی، دسترسی به شاهدانه پزشکی، داروهای ضد بارداری پزشکی، مقررات کانابیس، کانادا،
موضوعات مرتبط
علوم پزشکی و سلامت پزشکی و دندانپزشکی روانپزشکی و بهداشت روانی
چکیده انگلیسی

BackgroundIn 2001, Canada established a federal program for cannabis for therapeutic purposes (CTP). Medical cannabis dispensaries (dispensaries) are widely accessed as a source of CTP despite storefront sales of cannabis being illegal. The discrepancy between legal status and social practice has fuelled active debate regarding the role of dispensaries. The present study aims to inform this debate by analysing CTP user experiences with different CTP sources, and comparing dispensary users to those accessing CTP from other sources.MethodsWe compared sociodemographic characteristics, health related factors and patterns of cannabis use of 445 respondents, 215 who accessed CTP from dispensaries with 230 who accessed other sources. We compared patients' ratings of CTP sources (dispensaries, Health Canada's supplier, self-production, other producer, friend or acquaintance, street dealer) for quality and availability of product, safety and efficiency of access, cost, and feeling respected while accessing.ResultsPatients using dispensaries were older, more likely to have arthritis and HIV/AIDS, and less likely to have mental health conditions than those not using dispensaries. Those accessing dispensaries used larger quantities of cannabis, placed greater value on access to specific strains, and were more likely to have legal authorization for CTP. Dispensaries were rated equally to or more favourably than other sources of CTP for quality, safety, availability, efficiency and feeling respected, and less favourably than self-production and other producer for cost.ConclusionGiven the high endorsement of dispensaries by patients, future regulations should consider including dispensaries as a source of CTP and address known barriers to access such as cost and health care provider support. Further research should assess the impact of the addition of licensed producers on the role and perceived value of dispensaries within the Canadian medical cannabis system.

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: International Journal of Drug Policy - Volume 47, September 2017, Pages 1-8
نویسندگان
, , , , , , ,